Sanofi Multiple Sclerosis Drug Gets EU Approval – United Cultures

Cultural Unity and Shared ValuesDevelopment CooperationGlobal AlliancesGlobal CitizenshipGlobal Economic Shifts

Sanofi Multiple Sclerosis Drug Gets EU Approval

June 23, 2026

0

Sanofi said it received European Union approval for Cenrifki, a new multiple sclerosis medicine, after U.S. regulators rejected it.

Evolve Internet Smart Technology